Characterization of Recombinant Human IL-15 Deamidation and Its Practical Elimination through Substitution of Asparagine 77

Author： Nellis David   Michiel Dennis   Jiang Man-Shiow   Esposito Dominic   Davis Richard   Jiang Hengguang   Korrell Angela   Knapp George   Lucernoni Lauren   Nelson Roy   Pritt Emily   Procter Lauren   Rogers Mark   Sumpter Terry   Vyas Vinay   Waybright Timothy   Yang Xiaoyi   Zheng Amy   Yovandich Jason   Gilly John   Mitra George   Zhu Jianwei  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.29, Iss.3, 2012-03, pp. : 722-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multivariate Analysis of the Sequence Dependence of Asparagine Deamidation Rates in Peptides

By Kosky Andrew   Dharmavaram Vasumathi   Ratnaswamy Gayathri   Manning Mark  

Pharmaceutical Research, Vol. 26, Iss. 11, 2009-11 ,pp. : 2417-2428

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacological characterization of recombinant human and rat P2X receptor subtypes

By Bianchi B.R.   Lynch K.J.   Touma E.   Niforatos W.   Burgard E.C.   Alexander K.M.   Park H.S.   Yu H.   Metzger R.   Kowaluk E.   Jarvis M.F.   van Biesen T.  

European Journal of Pharmacology, Vol. 376, Iss. 1, 1999-07 ,pp. : 127-138

Elsevier

Access to resources Recommend Favorite

Recombinant Salmonella Vaccination Technology and Its Application to Human Bacterial Pathogens

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 2, 2013-02 ,pp. : 209-219

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Bioactivation and Toxicity of Leflunomide in Immortalized Human Hepatocytes and Kinetics of the Non-Enzymatic to Its Major etabolitie, A77 1726

By  

Drug Metabolism Letters, Vol. 2, Iss. 3, 2008-08 ,pp. : 153-157

Bentham Science Publishers

Access to resources Recommend Favorite

Sanofi Pasteur MSD's recombinant quadrivalent human papillomavirus (HPV) vaccine [Gardasil] has been launched in 15 EU countries

By  

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite